Long gap peripheral nerve injuries (i.e., gaps >3cm) remain a clinical challenge. When there is a long gap nerve injury, the standard of care is transplanting a nerve from one place in the body to the area where the defect is, a technique known as autografting. The use of an autograft requires a second surgical site resulting in longer operating times, and typically a sensory nerve is used to replace a motor/sensory nerve, which leaves an area of the body with permanent numbness. There are a handful of nerve guides on the market available to regenerate nerve gaps less than 3cm. However, there are no synthetic guides available having an FDA-approved indication for use in nerve gaps greater than three centimeters. Our patented technology utilizes a biodegradable tube containing a controlled drug delivery system supplying the cues necessary to promote the growth of nerves over large gaps, thus fulfilling this clinical unmet need.
We have developed a biodegradable polymer nerve guide (AxoMax) which
locally delivers bioactive neurotropic factors in the proper concentration to
cross from the proximal to distal nerve stump. Delivery of a drug that can
enhance nerve regeneration is used to overcome the current limitations in
nerve repair across large defects.
- There are no commercially available nerve guides to treat long gap (>3cm) nerve injuries.
- Weutilizeourpatentedslowdeliverysystemtoreleasedrugsover2-3 months during nerve regeneration.
- Inapivotallargeanimalmodel,AxoMaxperformedbetterthanthestandard of care (autograft) in a 5cm nerve defect.
• Traumatic injuries to peripheral nerves, including battlefield injuries. • Brachial plexus repair after shoulder injury.
• Nerve repair after tumor removal, such as prostatectomy.
• Post-Neuroma repair.
Stages of Development
Completed large preclinical studies; currently initiating GMP manufacturing and regulatory approval, and preparing for clinical trials.
2 Patents have been issued:
US patent application 15/668,959 in prosecution